PAD: Medtronic wins expanded FDA nod for Protégé GPS stent

Medtronic says it won a nod from the FDA for its Protégé GPS stent to treat peripheral artery disease in the common and external iliac arteries.

ev3 Inc., Covidien, Medtronic

News Well, Peripheral Artery Disease, Pre-Market Approval (PMA), Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1B1EkT8